Neutrophil extracellular traps in sterile inflammation: The story after dying?

Autoimmunity

Volumn 45, Issue 8, 2012, Pages 593-596

  Cui, Bei Bei ^a   Tan, Chun Yu ^a   Schorn, Christine ^b   Tang, Hong Hu ^a   Liu, Yi ^a   Zhao, Yi ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adaptive immunity; Autoimmune disease; Damage associated molecular patterns; Dendritic cells; Neutrophils

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD32 ANTIGEN; DEFENSIN; FC RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN G; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY COMPLEX; CELL DEATH; CELL STRUCTURE; CHROMATIN; DENDRITIC CELL; DNA MODIFICATION; ENDOSOME; GOUT; HUMAN; IMMUNOGENICITY; IMMUNOREGULATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; PHAGOCYTOSIS; PROTEIN MODIFICATION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADAPTIVE IMMUNITY; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; INFLAMMATION; MICE; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 84867949879     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.719952     Document Type: Review

References (40)

1. Tauber, A. I. 2003. Metchnikoff and the phagocytosis theory. Nat. Rev. Mol. Cell Biol 4: 897-901. (Pubitemid 37411727)
2. Brinkmann, V., U. Reichard, C. Goosmann C, et al. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535. (Pubitemid 38314426)
3. Menegazzi, R., E. Decleva, and P. Dri. 2012. Killing by neutrophil extracellular traps: fact or folklore? Blood 119: 1214-1216.
4. Remijsen, Q., T. W. Kuijpers, E. Wirawan, et al. 2011. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ 18: 581-588.
5. Rada, B., and T. L. Leto. 2008. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol 15: 164-187.
6. Hahn, S., A. K. Gupta, C. Troeger, et al. 2006. Disturbances in placental immunology: ready for therapeutic interventions? Springer. Semin Immunopathol 27: 477-493. (Pubitemid 43833129)
7. Metzler, K. D., T. A. Fuchs, W. M. Nauseef, et al. 2011. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innateimmunity. Blood 117: 953-959.
8. Kessenbrock, K., M. Krumbholz, U. Schönermarck, et al. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med 15: 623-625.
9. Hakkim, A., B. G. Fü rnrohr, K. Amann, et al. 2010. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA 107: 9813-9818.
10. Mantovani, A., M. A. Cassatella, C. Costantini, et al. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol 11: 519-531.
11. Tadema, H., W. H. Abdulahad, C. A. Stegeman, et al. 2011. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One 6: e24-315.
12. Lande, R., D. Ganguly, V. Facchinetti, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med 3: 73ra19.
13. Tillack, K., P. Breiden, R. Martin, et al. 2012. T lymphocyte priming neutrophil extracellular traps links innate and adaptive immuneresponses. J. Immunol 188: 3150-3159.
14. Dwivedi, N., J. Upadhyay, I. Neeli, et al. 2012. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum 64: 982-992.
15. Kessenbrock, K., M. Krumbholz, U. Schönermarck, et al. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med 15: 623-625.
16. Garcia-Romo, G. S., S. Caielli, B. Vega, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med 3: 73ra20.
17. Mitroulis, I., K. Kambas, A. Chrysanthopoulou, et al. 2011. Neutrophil extracellular trap formation is associated with IL-1b and autophagy-related signaling in gout. PLoS One 6: e29318.
18. Baker, V. S., G. E. Imade, N. B. Molta, et al. 2008. Cytokineassociated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar. J 7: 41.
19. Papayannopoulos, V., D. Staab, and A. Zychlinsky. 2011. Neutrophilelastaseenhancessputumsolubilization in cystic fibrosis patients receiving DNase therapy. PLoS One 6: e28526.
20. Csernok, E., P. Lamprecht, and W. L. Gross. 2010. Clinical and immunological features of drug-induced and infectioninducedproteinase3- antineutrophilcytoplasmicantibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr. Opin. Rheumatol 22: 43-48.
21. Dö ring, Y., H. Manthey, M. Drechsler, et al. 2012. Autoantigenicprotein-DNAcomplexesstimulateplasmacytoiddendriticcells to promote atherosclerosis. Circulation 125: 1673-1683.
22. Yan, J., X. Meng, L. M. Wancket, et al. 2012. Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps. J. Immunol 188: 2316-2327.
23. Munoz, L. E., C. Janko, R. A. Chaurio, et al. 2010. IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity 43: 232-235.
24. Munoz, L. E., C. Janko, G. E. Grossmayer, et al. 2009. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60: 1733-1742.
25. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, et al. 2002. Chromatin-IgG complexes activate B cells bydualengagement of IgM and Toll-likereceptors. Nature 416: 603-607. (Pubitemid 34406754)
26. Häcker, H., H. Mischak, T. Miethke, et al. 1998. CpG-DNAspecific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17: 6230-6240. (Pubitemid 28497796)
27. Zeng, D., M. K. Lee, J. Tung, et al. 2000. Cuttingedge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol 164: 5000-5004. (Pubitemid 30305168)
28. Bickerstaff, M. C., M. Botto, W. L. Hutchinson, et al. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 5: 694-697. (Pubitemid 29289434)
29. Leffler, J., M. Martin, B. Gullstrand, et al. 2012. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol 188: 3522-3531.
30. Fenton, K., S. Fismen, A. Hedberg, et al. 2009. Anti-dsDNA antibodies promote initiation, and acquired loss of renal DNase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One 4: e8474.
31. Fuchs, T. A., U. Abed, C. Goosmann, et al. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell. Biol 176: 231-241. (Pubitemid 46143263)
32. Doss, M., M. R.White, T. Tecle, et al. 2010. Human defensins and LL-37 in mucosal immunity. J. Leukoc. Biol 87: 79-92.
33. Denny, M. F., S. Yalavarthi, W. Zhao, et al. 2010. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol 184: 3284-3297.
34. Lamprecht, P., J. Holle, and W. L. Gross. 2009. Update on clinical, pathophysiological and therapeutic aspects in ANCAassociated vasculitides. Curr. Drug Discov. Technol 6: 241-251.
35. Phillipson, M., and P. Kubes. 2011. The neutrophil in vascular inflammation. Nat Med 17: 1381-1390.
36. Schorn, C., C. Janko, L. Munoz, et al. 2009. Sodium and potassium urate crystals differ in their inflammatory potential. Autoimmunity 42: 314-316.
37. Schorn, C., B. Frey, K. Lauber, et al. 2011. Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem 286: 35-41.
38. Mart́nez Valle, F., E. Balada, J. Ordi-Ros, et al. 2008. DNase 1 and systemic lupus erythematosus. Autoimmun. Rev 7: 359-363.
39. Gaubitz, M., M. Seidel, S. Kummer, et al. 1998. Prospectiverandomizedtrial of twodifferentimmunoadsorbers in severesystemiclupuserythematosus. J. Autoimmun 11: 495-501.
40. Urbonaviciute, V., and R. E. Voll. 2011. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J. Intern. Med 270: 309-318.